FORA Capital LLC Buys 9,412 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

FORA Capital LLC grew its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 76.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 21,763 shares of the company's stock after acquiring an additional 9,412 shares during the quarter. FORA Capital LLC's holdings in Henry Schein were worth $1,587,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. ING Groep NV purchased a new stake in Henry Schein during the 3rd quarter valued at about $63,226,000. Thompson Siegel & Walmsley LLC purchased a new stake in shares of Henry Schein during the second quarter valued at approximately $46,683,000. Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Henry Schein in the third quarter worth approximately $43,740,000. Bank of Montreal Can increased its stake in shares of Henry Schein by 365.6% in the third quarter. Bank of Montreal Can now owns 711,487 shares of the company's stock worth $52,095,000 after buying an additional 558,689 shares during the period. Finally, SG Americas Securities LLC raised its holdings in Henry Schein by 1,622.3% during the 3rd quarter. SG Americas Securities LLC now owns 458,828 shares of the company's stock valued at $33,449,000 after buying an additional 432,187 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on HSIC shares. JPMorgan Chase & Co. reduced their price target on Henry Schein from $88.00 to $80.00 and set an "overweight" rating on the stock in a report on Monday, August 12th. Robert W. Baird decreased their target price on Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a report on Wednesday, August 7th. Barrington Research reaffirmed an "outperform" rating and issued a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. Evercore ISI boosted their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a research report on Tuesday, October 8th. Finally, StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Six research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Henry Schein presently has a consensus rating of "Moderate Buy" and a consensus target price of $79.38.

Henry Schein Stock Up 0.5 %

NASDAQ HSIC traded up $0.38 during trading hours on Thursday, reaching $77.66. 832,776 shares of the company's stock traded hands, compared to its average volume of 1,400,600. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The firm has a 50-day simple moving average of $71.26 and a 200 day simple moving average of $69.84. The firm has a market cap of $9.68 billion, a PE ratio of 31.96, a PEG ratio of 2.20 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts' consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. During the same period in the previous year, the firm posted $1.32 EPS. The business's revenue for the quarter was up .4% compared to the same quarter last year. Sell-side analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Insider Transactions at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of the company's stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Lorelei Mcglynn sold 21,035 shares of the firm's stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares of the company's stock, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.